Syschem (India) Ltd. (SYSCHEM) Share Price Falls 16.92% Today
- August 4, 2026
- Posted by: Harsh Piplani
- Category: News
Syschem (India) Ltd. Share Price falls 16.92% today, marking a significant decline in the micro-cap category.
Syschem (India) Ltd. Share Price experienced a significant decline today, falling by 16.92% to close at Rs 35.49. The company’s market capitalisation now stands at Rs 229.05 crore. This sharp decline places Syschem (India) Ltd.
The decline in Syschem (India) Ltd.’s share price today is noteworthy, given the absence of a specific company-related catalyst in the supplied data. The stock opened at Rs 43.9 and reached a high of the same value before dropping to a low of Rs 34.18. The total turnover for the day was Rs 0.76 crore, with a volume of 214,508 shares traded on the BSE.
Syschem (India) Ltd. (SYSCHEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 35.49 |
| Previous Close | Rs 42.72 |
| Today's Change | Rs -7.23 (-16.92%) |
| Day Open | Rs 43.9 |
| Day High | Rs 43.9 |
| Day Low | Rs 34.18 |
| Current Volume (BSE) | 2,14,508 |
| BSE Traded Volume | 2,14,508 |
| Combined NSE + BSE Volume | 2,14,508 |
| Turnover | Rs 0.76 crore |
| Market Capitalisation | Rs 229.05 crore |
| Market Cap Category | Micro Cap |
Syschem (India) Ltd. (SYSCHEM) traded at Rs 35.49. versus the previous close of Rs 42.72, a fall of 16.92%. The stock opened at Rs 43.9, reached Rs 43.9, touched Rs 34.18. Reported volume was 2,14,508.
Syschem (India) Ltd. (SYSCHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 229.05 crore |
| P/E Ratio | 20.96x |
| P/B Ratio | 1.59x |
| ROE | -66.17% |
| ROCE | -29.75% |
| EPS | Rs 2.04 |
| Dividend Yield | 0% |
Syschem (India) Ltd. was valued at a P/E ratio of 20.96x, a P/B ratio of 1.59x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -66.17% and ROCE of -29.75%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 2.04, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Syschem (India) Ltd. has a market capitalisation of Rs 229.05 crore, placing it in the micro-cap category. The company’s price-to-earnings (P/E) ratio is 20.96, which is below the industry median of 25.88 but above the minimum of 3.41. This suggests that the stock is relatively fairly valued compared to its industry peers.
The price-to-book (P/B) ratio is 1.59, slightly below the industry median of 1.77, indicating a modest valuation relative to the company’s book value. However, the return on equity (ROE) is significantly negative at -66.17%, and the return on capital employed (ROCE) is -29.75%, both of which are well below the industry averages of 10.7% and 12.98%, respectively.
The company’s earnings per share (EPS) stands at Rs 2.04, and it does not offer a dividend yield, which may be a consideration for income-focused investors. The negative ROE and ROCE highlight challenges in generating returns on shareholder equity and capital employed, which could impact investor sentiment.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 20.96x |
| Benchmark Median P/E | 25.88x |
| Benchmark Average P/E | 69.32x |
| Benchmark P/E Range | 3.41x to 3,364.06x |
| Company P/B Ratio | 1.59x |
| Benchmark Median P/B | 1.77x |
| Company ROE | -66.17% |
| Benchmark Median ROE | 10.7% |
| Company ROCE | -29.75% |
| Benchmark Median ROCE | 12.98% |
| Company Market Capitalisation | Rs 229.05 crore |
| Benchmark Median Market Cap | Rs 146.46 crore |
Syschem (India) Ltd. (SYSCHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Syschem (India) Ltd. (SYSCHEM) has a P/E ratio of 20.96x, which is below the benchmark median of 25.88x, a difference of -19.01%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Syschem (India) Ltd. (SYSCHEM) has a ROE of -66.17%, which is below the benchmark median of 10.7%, a difference of -718.41%. Syschem (India) Ltd. (SYSCHEM) has a ROCE of -29.75%, which is below the benchmark median of 12.98%, a difference of -329.2%.
Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Syschem (India) Ltd. operates within the Healthcare sector, specifically in the Pharmaceuticals & Drugs industry. The sector benchmark includes 137 companies, providing a comprehensive view of the industry’s performance metrics.
The company’s P/E ratio of 20.96 is below the industry median of 25.88, suggesting a relatively fair valuation. However, the negative ROE and ROCE are concerning, as they are significantly below the industry averages of 10.7% and 12.98%, respectively.
The Healthcare sector, particularly Pharmaceuticals & Drugs, is known for its competitive landscape and regulatory challenges. Syschem (India) Ltd.’s market capitalisation of Rs 229.05 crore is below the industry median of Rs 146.46 crore, indicating its smaller size within the sector.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,931.84 | 0 | 0.76 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,731.11 | 0 | 2.37 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,683.28 | 39.39 | 7.98 | 28.21 | 26.35 |
| Panacea Biotec Ltd. | PANACEABIO | 2,580.49 | 0 | 9.08 | 0 | 5.36 |
| Beta Drugs Ltd. | BETA | 2,474.26 | 62.88 | 9.95 | 18.65 | 22.17 |
Syschem (India) Ltd. (SYSCHEM) has a P/E ratio of 20.96x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -66.17% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at -29.75% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Syschem (India) Ltd. (SYSCHEM) has a market capitalisation of Rs 229.05 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
In comparison to its peers, Syschem (India) Ltd. has a market capitalisation of Rs 229.05 crore, which is significantly lower than companies like Dishman Carbogen Amcis Ltd. (Rs 2931.84 crore) and Hikal Ltd. (Rs 2731.11 crore). The company’s P/E ratio of 20.96 is lower than Kwality Pharmaceuticals Ltd.’s 39.39 and Beta Drugs Ltd.’s 62.88, indicating a relatively fair valuation.
However, Syschem (India) Ltd.’s negative ROE of -66.17% contrasts sharply with peers like Kwality Pharmaceuticals Ltd. (28.21%) and Hikal Ltd. (15.22%). The company’s ROCE of -29.75% is also significantly lower than the peer average, highlighting operational challenges.
Why Investors Are Watching Syschem (India) Ltd.
Syschem (India) Ltd. has captured investor attention due to its significant price fall today and its position within the competitive Pharmaceuticals & Drugs industry.
- Price Action: The stock fell 16.92%, closing at Rs 35.49.
- Technical Position: RSI indicates neutral momentum.
- Fundamental Context: Negative ROE and ROCE highlight challenges.
- Ownership: No specific ownership data supplied.
- Sector Positioning: Operates in a competitive industry with regulatory challenges.
Investors should monitor the company’s financial performance and industry developments to assess potential risks and opportunities.
About Syschem (India) Ltd.
Syschem (India) Ltd. operates in the Pharmaceuticals & Drugs industry, focusing on the production and distribution of pharmaceutical products. The company is part of the Healthcare sector, which is known for its dynamic and competitive nature.
Syschem (India) Ltd. aims to provide quality pharmaceutical products to meet the needs of the healthcare industry. The company’s operations are subject to regulatory standards and industry trends, which can impact its performance and growth prospects.
Track Syschem (India) Ltd. Share Price on Univest
Use Syschem (India) Ltd. (SYSCHEM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.
Investors can track Syschem (India) Ltd. Share Price on Univest for real-time updates on share price, technical indicators, fundamental ratios, and market insights. Univest provides comprehensive data to help investors make informed decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What caused the Syschem (India) Ltd. share price to fall today?
Ans. The Syschem (India) Ltd. share price fell 16.92% today, closing at Rs 35.49. The decline was significant, but no specific company-related catalyst was identified in the supplied data. The stock moved -16.92% during the session.
What is the current market capitalisation of Syschem (India) Ltd.?
Ans. Syschem (India) Ltd. has a current market capitalisation of Rs 229.05 crore, placing it in the micro-cap category within the Pharmaceuticals & Drugs industry. The company operates in the Healthcare sector.
How does Syschem (India) Ltd.'s P/E ratio compare to the industry?
Ans. Syschem (India) Ltd.'s P/E ratio is 20.96, which is below the industry median of 25.88, indicating a relatively fair valuation compared to its peers. The company trades at a P/E ratio of 20.96x.
How does Syschem (India) Ltd.'s ROE compare to its peers?
Ans. Syschem (India) Ltd.'s ROE of -66.17% is significantly lower than peers like Kwality Pharmaceuticals Ltd. (28.21%) and Hikal Ltd. (15.22%), highlighting operational challenges. ROE stands at -66.17%. ROCE stands at -29.75%.
What is the sector context for Syschem (India) Ltd.?
Ans. Syschem (India) Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector, known for its competitive landscape and regulatory challenges. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.
How does Syschem (India) Ltd.'s market cap compare to the industry?
Ans. Syschem (India) Ltd.'s market cap of Rs 229.05 crore is below the industry median of Rs 146.46 crore, indicating its smaller size within the sector. The company operates in the Healthcare sector.
